Lamberto Andreotti (born 6 July 1950) is an Italian businessman. He is currently executive chairman of the board of Bristol Myers Squibb.

Biography

Early life

Andreotti was born in

Rome , established_title = Founded , established_date = 753 BC , founder = King Romulus (legendary) , image_map = Map of comune of Rome (metropolitan city of Capital Rome, region Lazio, Italy).svg , map_caption ...

, Italy, in 1950, the son of Italian Senator and President of the Council of Ministers Giulio Andreotti. He graduated from

Sapienza University of Rome The Sapienza University of Rome ( it, Sapienza – Università di Roma), also called simply Sapienza or the University of Rome, and formally the Università degli Studi di Roma "La Sapienza", is a public research university located in Rome, Ita ...

with a degree in engineering; he then earned a Master of Science degree from

Massachusetts Institute of Technology The Massachusetts Institute of Technology (MIT) is a private land-grant research university in Cambridge, Massachusetts. Established in 1861, MIT has played a key role in the development of modern technology and science, and is one of the ...

.Forbes
/ref>

Professional roles

He worked for many pharmaceutical companies, including

Farmitalia-Carlo Erba Farmitalia was an Italian pharmaceutical company best known for its parallel discovery with Rhone-Poulenc of daunorubicin and subsequent discovery of doxorubicin. Farmitalia had been founded in 1935 as a joint venture by Rhone-Poulenc and Monte ...

then with

Pharmacia Pharmacia was a pharmaceutical and biotechnological company in Sweden that merged with the American pharmaceutical company Upjohn in 1995. History Pharmacia company was founded in 1911 in Stockholm, Sweden by pharmacist Gustav Felix Grönfeldt ...

after Pharmacia acquired

Farmitalia Farmitalia was an Italian pharmaceutical company best known for its parallel discovery with Rhone-Poulenc of daunorubicin and subsequent discovery of doxorubicin. Farmitalia had been founded in 1935 as a joint venture by Rhone-Poulenc and Monte ...

. In 1998, he joined Bristol-Myers Squibb as vice president and general manager of European Oncology and Italy. He was elected to the Board of Directors in March 2009 and became CEO on 4 May 2010. Prior to taking the role of CEO, he held the role of president and

COO COO or coo may refer to: Business * Certificate of origin, used in international trade * Chief operating officer or chief operations officer, high-ranking corporate official * Concept of operations, used in Systems Engineering Management Process ...

. He retired from Bristol-Myers Squibb in 2015 and took on the role of executive chairman of the company's board, succeeding James M. Cornelius who was retiring from this role. He was elected to the board of DuPont in 2012. He was elected to the Board of Directors of

UniCredit UniCredit S.p.A. is an international banking group headquartered in Milan. It is Italy's only systemically important bank (according to the list provided by the Financial Stability Board in 2022) and the world's 34th largest by assets. It was fo ...

S.p.A. Bank on 12 May 2018.

References

Italian chief executives Bristol Myers Squibb people Directors of DuPont Living people 1950 births Businesspeople from Rome Sapienza University of Rome alumni Massachusetts Institute of Technology alumni Chief operating officers Chief executives in the pharmaceutical industry Children of prime ministers of Italy {{Italy-business-bio-stub